An analysis of studies of the popular diabetes drug Avandia suggests that it may be doing more harm than good. Steve Nissen, MD, of the Cleveland Clinic describes his concerns with this drug.
Dr. Nissen’s study was published in The New England Journal of Medicine. It was accompanied by an editorial. Curt Furberg, MD, one of the editorialists, tells us how the Avandia issue highlights problems at the FDA.
Some researchers have found evidence that a traditional Mexican folk remedy, prickly pear cactus leaves, can help diabetics control blood sugar.
The lines are open for calls from listeners at 888-472-3366.
Guests: Steven Nissen, MD, cardiologist at the Cleveland Clinic and co-author of “Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes,” New England Journal of Medicine.
Curt Furberg, MD, Professor of Public Health Sciences at Wake Forest University School of Medicine and co-author of “Rosiglitazone and Cardiovascular Risk” (editorial), New England Journal of Medicine.
